VANCOUVER, BC, Nov. 24, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYD) (FSE: 0YL) (the “Company“) announces that the Company has entered into a new convertible security funding agreement (the “Agreement“) with Lind Global […]
Tag: Else Nutrition Holdings Inc.
President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
New Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed VANCOUVER, BC, Nov. 18, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) […]
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Conference call to be held on Monday, November 17 at 10:00 AM Eastern Time VANCOUVER, BC, Nov. 14, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today reported financial results […]
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
Conference Call will Now be Held on Monday, November 17th at 10:00 AM Eastern Time VANCOUVER, BC, Nov. 13, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today announced the […]
ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
Vancouver, BC, Nov. 3, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company”) announces that the Company’s board of directors has approved a consolidation of the Company’s common shares on […]
















